Tesamorelin, also known as growth hormone-releasing factor (GRF) or TH9507, is a synthetic analog of growth hormone-releasing hormone (GHRH) that is used to stimulate the release of growth hormone (GH) from the pituitary gland. It is primarily used to reduce visceral fat in HIV-infected patients with lipodystrophy, a condition characterized by abnormal fat distribution. Tesamorelin works by increasing GH levels, which in turn promotes fat loss, improves body composition, and enhances overall metabolic health. Its targeted action on GH release and effectiveness in reducing visceral fat make Tesamorelin a valuable therapeutic agent in both clinical and metabolic health settings.

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH), known for its nootropic, neuroprotective, and neuroregenerative properties. It works by modulating the activity of neurotransmitters and enhancing the expression of neurotrophic factors like BDNF (brain-derived neurotrophic factor). Semax is used to improve cognitive function, enhance memory, and protect against neurodegenerative diseases. It is also noted for its ability to reduce symptoms of stress and improve mood. Semax’s multifaceted effects on brain health and cognitive function make it a promising candidate in the fields of nootropics and neuroprotection.